Private Advisor Group, LLC Bluebird Bio, Inc. Transaction History

Private Advisor Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Apr 01, 2021	SELL	$27.5 - $37.92 $142,670 - $196,728	-5,188 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$34.44 - $43.75 $7,335 - $9,318	213 Added 4.28%	5,188 $280,000
Q2 2020 Aug 17, 2020	BUY	$27.12 - $45.97 $134,922 - $228,700	4,975 New	4,975 $304,000
Q1 2020 May 12, 2020	SELL	$26.16 - $63.5 $77,930 - $189,166	-2,979 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$46.96 - $61.67 $892 - $1,171	-19 Reduced 0.63%	2,979 $261,000
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $53,641 - $83,976	-902 Reduced 23.13%	2,998 $275,000
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $3,488 - $4,839	46 Added 1.19%	3,900 $496,000
Q1 2019 May 13, 2019	BUY	$64.44 - $104.11 $3,673 - $5,934	57 Added 1.5%	3,854 $606,000
Q4 2018 Feb 11, 2019	BUY	$59.1 - $93.26 $23,580 - $37,210	399 Added 11.74%	3,797 $375,000
Q3 2018 Nov 01, 2018	BUY	$88.86 - $117.49 $88,860 - $117,490	1,000 Added 41.7%	3,398 $496,000
Q2 2018 Aug 09, 2018	BUY	$99.64 - $127.59 $9,465 - $12,121	95 Added 4.13%	2,398 $373,000
Q1 2018 May 09, 2018	SELL	$105.8 - $150.94 $14,177 - $20,225	-134 Reduced 5.5%	2,303 $393,000
Q4 2017 Feb 07, 2018	SELL	$81.25 - $130.7 $23,237 - $37,380	-286 Reduced 10.5%	2,437 $415,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $11,086 - $17,552	192 Added 7.59%	2,723 $358,000
Q2 2017 Aug 10, 2017	BUY	N/A	2,531	2,531 $238,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.